Obesity, demographic, and lifestyle risk factor patterns associated with endometrial cancer diagnosis and survival: insights from the Women's Health Initiative

Background: Obesity, the major risk factor for endometrial cancer, has varying prevalence geographically. We aimed to examine patterns in obesity, demographic characteristics, lifestyle risk factors and histopathologic features among women with and without endometrial cancer and to evaluate their association with survival outcomes. Methods: We utilized data from the Women’s Health Initiative cohort study to analyze 93,676 postmenopausal women with a uterus enrolled between 1993 and 1998, followed through 2021. Demographic and lifestyle characteristics were compared between women with and without endometrial cancer using absolute standardized mean differences. Histologic subtype and stage at diagnosis were stratified by race and geographic region. Multivariable Cox proportional hazards models assessed associations between demographic and lifestyle factors and survival. Kaplan-Meier curves and log-rank tests compared survival by region. Results: Our cohort included 92,040 participants without and 1826 participants with incident endometrial cancer over a mean 16.7 (±7.36) years of follow-up. Women with endometrial cancer were more likely to be obese (BMI (body mass index) ≥30), non-Hispanic White, and have hypertension and diabetes. Obesity conferred a higher risk of endometrial cancer, but its effect was not modified by race. Histologic subtype and stage at diagnosis varied by race and region, with women in the South having a higher prevalence of aggressive histologies and advanced-stage cancers. Survival did not differ significantly by region (log-rank p = 0.187) and White vs. Black race did not modify this association (p = 0.857). Conclusions: These findings contribute to our understanding of endometrial cancer epidemiology and highlight the importance of considering racial disparities and histologic subtypes when studying the disease. While survival outcomes did not differ significantly by geographic region, notable disparities in tumor characteristics highlight the importance of a uniform focus on obesity prevention. Equitable access to prevention, early detection and treatment strategies can help inform health policy at the national level.

Endometrial cancer; Obesity; Geographic variation; Survival; Histology; Risk factors; Race

[1] American Cancer Society. Key statistics for endometrial cancer. 2025. Available at: www.cancer.org/cancer/types/endometrial-cancer/about/key-statistics.html (Accessed: 05 April 2025).

[2] National Cancer Institute. Cancer stat fact sheets: uterine cancer. 2021. Available at: http://seer.cancer.gov/statfacts/html/corp.html (Accessed: 05 April 2025).

[3] Webb PM. Obesity and gynecologic cancer etiology and survival. American Society of Clinical Oncology Educational Book. 2013; 33: e222–e228.

[4] Singh G, Cue L, Puckett Y. Endometrial Hyperplasia. StatPearls: Treasure Island. 2024.

[5] Centers for Disease Control and Prevention. Adult obesity prevalence maps. 2024. Available at: https://www.cdc.gov/obesity/data-and-statistics/adult-obesity-prevalence-maps.html (Accessed: 05 April 2025).

[6] Felix AS, Nafiu T, Cosgrove CM, Ewing AP, Mpody C. Racial disparities in surgical outcomes among women with endometrial cancer. Annals of Surgical Oncology. 2022; 29: 8338–8344.

[7] Karia PS, Huang Y, Tehranifar P, Wright JD, Genkinger JM. Racial and ethnic differences in type II endometrial cancer mortality outcomes: the contribution of sociodemographic, clinicopathologic, and treatment factors. Gynecologic Oncology. 2023; 168: 119–126.

[8] Design of the Women’s Health Initiative clinical trial and observational study. The Women’s Health Initiative study group. Controlled clinical trials. 1998; 19: 61–109.

[9] Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al.; Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002; 288: 321–333.

[10] Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, et al.; WHI Morbidity and Mortality Committee. Outcomes ascertainment and adjudication methods in the Women’s Health Initiative. Annals of Epidemiology. 2003; 13: S122–S128.

[11] Reeves KW, Carter GC, Rodabough RJ, Lane D, McNeeley SG, Stefanick ML, et al. Obesity in relation to endometrial cancer risk and disease characteristics in the Women’s Health Initiative. Gynecologic Oncology. 2011; 121: 376–382.

[12] Cohen J. The effect size index: d. In Cohen J (ed.) Statistical Power Analysis for the Behavioral Sciences (pp. 19–74). 2nd edn. Lawrence Erlbaum Associates: Hillsdale, NJ. 1988.

[13] Krebs-Smith SM, Pannucci TE, Subar AF, Kirkpatrick SI, Lerman JL, Tooze JA, et al. Update of the healthy eating index: HEI-2015. Journal of the Academy of Nutrition and Dietetics. 2018; 118: 1591–1602.

[14] Reavey JJ, Walker C, Murray AA, Brito-Mutunayagam S, Sweeney S, Nicol M, et al. Obesity is associated with heavy menstruation that may be due to delayed endometrial repair. Journal of Endocrinology. 2021; 249: 71–82.

[15] Folkerd EJ, James VH. Aromatization of steroids in peripheral tissues. Journal of Steroid Biochemistry. 1983; 19: 687–690.

[16] Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism. 1973; 36: 207–214.